Enanta Pharmaceuticals (ENTA) Preferred Dividend Payments (2012 - 2013)
Enanta Pharmaceuticals' (ENTA) quarterly Preferred Dividend Payments came in at -$5.1 million in Q3 2013, down 479.28% YoY from $1.3 million in Q3 2012, and down 506.11% on a QoQ basis from $1.2 million in Q1 2013.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 2 years of Preferred Dividend Payments data on file, last reported at -$5.1 million in Q3 2013.
- Quarterly Preferred Dividend Payments fell 479.28% year-over-year to -$5.1 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $15.0 million (changed N/A YoY) and the FY2013 annual result came in at -$2.5 million, down 147.07% from the prior year.
- Preferred Dividend Payments retreated to -$5.1 million in Q3 2013, from $1.2 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $28.2 million in Q1 2012 to a low of -$5.1 million in Q3 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Enanta Pharmaceuticals | 410.46 Mn | 220.95 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 1.24 Mn |
| Dec 31, 2012 | 18.81 Mn |
| Sep 30, 2012 | -4.94 Mn |
| Jun 30, 2012 | 1.33 Mn |
| Mar 31, 2012 | 28.15 Mn |